Literature DB >> 3390669

Prognosis of colorectal cancer in the elderly.

T T Irvin1.   

Abstract

The prognosis of colorectal cancer in the elderly was examined in a study of 306 consecutive patients. The patients were divided into two groups: Group 1 included 171 patients of average age 77 years (range 70-97); Group 2 comprised 135 patients of average age 59 years (range 22-69). There was no significant difference between the two groups with regard to the mode of presentation, the location and Duke's classification of the tumours, the incidence of palliative operations, and the perioperative mortality. The surgical mortality rates in Group 1 were 6 per cent overall, 4 per cent after elective operations, and 16 per cent after emergency surgery; the corresponding mortality rates for Group 2 were 3 per cent, 1 per cent, and 20 per cent. Emergency surgery was associated with a significantly higher incidence of perioperative death at any age (P less than 0.001) and most deaths resulted from complications of coexisting medical disorders or thrombo-embolic complications. Crude actuarial 5-year survival curves showed an increased death rate in Group 1 after 18 months and a significantly lower 5-year survival (P less than 0.05) but the age-corrected survival curves for the two groups were not significantly different, and it was concluded that the prognosis for colorectal cancer in the elderly is not significantly different from that of younger patients.

Entities:  

Mesh:

Year:  1988        PMID: 3390669     DOI: 10.1002/bjs.1800750508

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  27 in total

1.  Coloanal anastomosis after resection of low rectal cancer in the elderly.

Authors:  C Huguet; J Harb; S Bona
Journal:  World J Surg       Date:  1990 Sep-Oct       Impact factor: 3.352

Review 2.  Laparoscopic versus open colorectal resection in the elderly population.

Authors:  Katherine Grailey; Sheraz R Markar; Alan Karthikesalingam; Rima Aboud; Paul Ziprin; Omar Faiz
Journal:  Surg Endosc       Date:  2012-06-30       Impact factor: 4.584

3.  Outcomes of surgery for mid and distal rectal cancer in the elderly.

Authors:  Wai Lun Law; Hok Kwok Choi; Judy Wc Ho; Yee Man Lee; Chi Leung Seto
Journal:  World J Surg       Date:  2006-04       Impact factor: 3.352

4.  Colorectal cancer surgery in the elderly: limitations and drawbacks.

Authors:  D Symeonidis; G Christodoulidis; G Koukoulis; M Spyridakis; K Tepetes
Journal:  Tech Coloproctol       Date:  2011-10       Impact factor: 3.781

Review 5.  Defining treatment aims and end-points in older patients with cancer.

Authors:  C E Desch; T J Smith
Journal:  Drugs Aging       Date:  1995-05       Impact factor: 3.923

6.  Esophagectomy for carcinoma of the esophagus in the elderly: results of current surgical management.

Authors:  R T Poon; S Y Law; K M Chu; F J Branicki; J Wong
Journal:  Ann Surg       Date:  1998-03       Impact factor: 12.969

7.  The influence of age on resection rates and postoperative mortality in 6457 patients with colorectal cancer.

Authors:  R A Damhuis; J C Wereldsma; T Wiggers
Journal:  Int J Colorectal Dis       Date:  1996       Impact factor: 2.571

8.  Radiochemotherapy and brachytherapy could be the standard treatment for anal canal cancer in elderly patients? A retrospective single-centre analysis.

Authors:  Laetitia Lestrade; Berardino De Bari; Xavier Montbarbon; Pascal Pommier; Christian Carrie
Journal:  Med Oncol       Date:  2013-01-16       Impact factor: 3.064

9.  Curative colorectal resections in patients aged 80 years and older: clinical characteristics, morbidity, mortality and risk factors.

Authors:  Ugochukwu Ihedioha; Gianpiero Gravante; Geraint Lloyd; Sam Sangal; Roberto Sorge; Baljit Singh; Sanjay Chaudhri
Journal:  Int J Colorectal Dis       Date:  2012-12-15       Impact factor: 2.571

10.  Risk factors and operative mortality in surgery for colorectal cancer.

Authors:  S C Brown; J S Abraham; S Walsh; P A Sykes
Journal:  Ann R Coll Surg Engl       Date:  1991-09       Impact factor: 1.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.